Ausgabe 1/2017
Inhalt (10 Artikel)
Future Paradigms of HCV Management with Resistance Testing
Lucas A. Hill, David L. Wyles
Use of Hepatitis C-Positive Donor Livers in Liver Transplantation
Daniel Bushyhead, David Goldberg
Treatment of Hepatitis C in Children
Kathleen B. Schwarz, Wikrom Karnsakul
NAFLD-Related HCC: How Should the Shift in Epidemiology Change Our Prevention and Surveillance Strategies?
J. Andy Tau, Aaron P. Thrift, Fasiha Kanwal
Changes in Liver Transplant Criteria for Hepatocellular Carcinoma
Dekey Lhewa, Neehar D. Parikh
Racial/Ethnic Disparities in Hepatocellular Carcinoma Epidemiology
John Ha, Melissa Yan, Robert J. Wong
Liver Biopsy for Hepatocellular Carcinoma (HCC): Should this be a Routine?
Adam Doyle, Morris Sherman
Advances in Pediatric Liver Tumors
Angela D. Trobaugh-Lotrario, Allison F. O’Neill, Peng Li, Alexander Towbin, Christopher Weldon, Dolores López-Terrada, Marcio H. Malogolowkin
Tailored Algorithms for Hepatocellular Carcinoma Surveillance: Is One-Size-Fits-All Strategy Outdated?
Nicolas Goossens, C. Billie Bian, Yujin Hoshida
Understanding LI-RADS, Its Relationship to AASLD and OPTN, and the Challenges of Its Adoption
Joseph H. Yacoub, Frank H. Miller